{"created":"2023-06-19T07:25:22.224839+00:00","id":13131,"links":{},"metadata":{"_buckets":{"deposit":"551f69dd-0372-4be3-8e46-c4a2b33edeae"},"_deposit":{"created_by":39,"id":"13131","owners":[39],"pid":{"revision_id":0,"type":"depid","value":"13131"},"status":"published"},"_oai":{"id":"oai:gifu-pu.repo.nii.ac.jp:00013131","sets":["212:361:364"]},"author_link":["18573","18572","18574"],"item_3_biblio_info_3":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-05-06","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{},{"bibliographic_title":"Therapeutic innovation & regulatory science","bibliographic_titleLang":"en"}]}]},"item_3_text_4":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_text_value":"https://doi.org/10.1177/2168479018769288"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Influence of Expedited Programs in the United States on Oncology Drug Development in Japan.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Influence of Expedited Programs in the United States on Oncology Drug Development in Japan.","subitem_title_language":"en"}]},"item_type_id":"3","owner":"39","path":["364"],"pubdate":{"attribute_name":"公開日","attribute_value":"2018-06-14"},"publish_date":"2018-06-14","publish_status":"0","recid":"13131","relation_version_is_last":true,"title":["Influence of Expedited Programs in the United States on Oncology Drug Development in Japan."],"weko_creator_id":"39","weko_shared_id":-1},"updated":"2023-06-19T08:58:53.491907+00:00"}